Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Tissue-based multigene expression tests for pretreatment prostate cancer risk assessment: current status and future perspectives.

Hiser WM, Sangiorgio V, Bollito E, Esnakula A, Feely M, Falzarano SM.

Future Oncol. 2018 Aug 15. doi: 10.2217/fon-2018-0287. [Epub ahead of print]

PMID:
30107751
2.

End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy.

Chen JC, Thorsteinsdottir B, Vaughan LE, Feely MA, Albright RC, Onuigbo M, Norby SM, Gossett CL, D'Uscio MM, Williams AW, Dillon JJ, Hickson LJ.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1172-1179. doi: 10.2215/CJN.00590118. Epub 2018 Jul 19.

PMID:
30026285
3.

Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.

Zhou W, Huang Y, Lai J, Lu J, Feely M, Liu X.

Gastroenterology Res. 2018 Jun;11(3):174-188. doi: 10.14740/gr1041w. Epub 2018 May 31. Review.

4.

Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists.

Wu XR, Liu HS, Shi XY, Zhou WX, Jiang ZN, Huang Y, Karamchandani DM, Goldblum JR, Xiao SY, Zhu HF, Feely MM, Collinsworth AL, Esnakula A, Xie H, Shen B, Lan P, Liu XL.

Gastroenterol Res Pract. 2018 Apr 23;2018:8715263. doi: 10.1155/2018/8715263. eCollection 2018.

5.

Malignant Peritoneal Mesothelioma Presenting as Mucinous Ascites.

Field Z, Zori A, Khullar V, Mota M, Feely M, Firpi RJ.

ACG Case Rep J. 2018 Mar 14;5:e23. doi: 10.14309/crj.2018.23. eCollection 2018.

6.

Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells.

Han S, Gonzalo DH, Feely M, Rinaldi C, Belsare S, Zhai H, Kalra K, Gerber MH, Forsmark CE, Hughes SJ.

Oncotarget. 2017 Dec 20;9(5):5764-5777. doi: 10.18632/oncotarget.23532. eCollection 2018 Jan 19.

7.

Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT.

Smith CJ, Wang MX, Feely M, Otto B, Grajo JR.

J Radiol Case Rep. 2017 May 31;11(5):27-33. doi: 10.3941/jrcr.v11i5.3117. eCollection 2017 May.

8.

Clinical Pearls in palliative medicine.

Feely MA, Litin SC, Bundrick JB.

Dis Mon. 2017 Jun;63(6):134-140. doi: 10.1016/j.disamonth.2017.03.013. No abstract available.

PMID:
28651689
9.

Immune modulator-induced changes in the gastrointestinal tract - reply.

Gonzalez RS, Salaria SN, Bohannon CD, Huber AR, Feely MM, Shi C.

Histopathology. 2017 Sep;71(3):496. doi: 10.1111/his.13233. Epub 2017 Jun 16. No abstract available.

PMID:
28387954
10.

Do patients receiving hemodialysis regret starting dialysis? A survey of affected patients
.

Gilman EA, Feely MA, Hildebrandt D, Edakkanambeth Varayil J, Chong EY, Williams AW, Mueller PS.

Clin Nephrol. 2017 Mar;87 (2017)(3):117-123. doi: 10.5414/CN109030.

PMID:
28128729
11.

PD-1 inhibitor gastroenterocolitis: case series and appraisal of 'immunomodulatory gastroenterocolitis'.

Gonzalez RS, Salaria SN, Bohannon CD, Huber AR, Feely MM, Shi C.

Histopathology. 2017 Mar;70(4):558-567. doi: 10.1111/his.13118. Epub 2016 Dec 20.

PMID:
28000302
12.

Massive gastric juvenile-type polyposis: a clinicopathological analysis of 22 cases.

Gonzalez RS, Adsay V, Graham RP, Shroff SG, Feely MM, Drage MG, Lewin DN, Swanson EA, Yantiss RK, Bağci P, Krasinskas AM.

Histopathology. 2017 May;70(6):918-928. doi: 10.1111/his.13149. Epub 2017 Feb 16.

PMID:
27991685
13.

Child Welfare Involved Parents and Pathways Triple P: Perceptions of Program Acceptability and Appropriateness.

Lewis EM, Feely M, Seay KD, Fedoravicis N, Kohl PL.

J Child Fam Stud. 2016 Dec;25(12):3760-3770. Epub 2016 Sep 12.

14.

Prevalence and Contents of Advance Directives of Patients with ESRD Receiving Dialysis.

Feely MA, Hildebrandt D, Edakkanambeth Varayil J, Mueller PS.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2204-2209. Epub 2016 Nov 17.

15.

The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stroma.

Han S, Gonzalo DH, Feely M, Delitto D, Behrns KE, Beveridge M, Zhang D, Thomas R, Trevino JG, Schmittgen TD, Hughes SJ.

Oncotarget. 2016 Jul 20;8(33):54054-54067. doi: 10.18632/oncotarget.10722. eCollection 2017 Aug 15.

16.

Reengineering Dialysis: The Role of Palliative Medicine.

Feely MA, Swetz KM, Zavaleta K, Thorsteinsdottir B, Albright RC, Williams AW.

J Palliat Med. 2016 Jun;19(6):652-5. doi: 10.1089/jpm.2015.0181. Epub 2016 Mar 18.

PMID:
26991732
17.

Novel psoriasis therapies and patient outcomes, Part 3: Systemic medications.

Feely MA, Smith BL, Weinberg JM.

Cutis. 2015 Jul;96(1):47-53.

PMID:
26244353
18.

Novel psoriasis therapies and patient outcomes, part 2: biologic treatments.

Feely MA, Smith BL, Weinberg JM.

Cutis. 2015 May;95(5):282-90.

PMID:
26057506
19.

Novel psoriasis therapies and patient outcomes, part 1: topical medications.

Feely MA, Smith BL, Weinberg JM.

Cutis. 2015 Mar;95(3):164-8, 170. Review.

PMID:
25844785
20.

A survey of clinician attitudes and self-reported practices regarding end-of-life care in heart failure.

Dunlay SM, Foxen JL, Cole T, Feely MA, Loth AR, Strand JJ, Wagner JA, Swetz KM, Redfield MM.

Palliat Med. 2015 Mar;29(3):260-7. doi: 10.1177/0269216314556565. Epub 2014 Dec 8.

PMID:
25488909
21.

Palliative Sedation and What Constitutes Active Dying: A Case of Severe Progressive Dystonia and Intractable Pain.

Strand JJ, Feely MA, Kramer NM, Moeschler SM, Swetz KM.

Am J Hosp Palliat Care. 2016 May;33(4):363-8. doi: 10.1177/1049909114561997. Epub 2014 Dec 7.

PMID:
25487783
22.

Ethical challenges with hemodialysis patients who lack decision-making capacity: behavioral issues, surrogate decision-makers, and end-of-life situations.

Feely MA, Albright RC, Thorsteinsdottir B, Moss AH, Swetz KM.

Kidney Int. 2014 Sep;86(3):475-80. doi: 10.1038/ki.2014.231. Epub 2014 Jul 2.

23.

IgG4-related cholecystitis presenting as biliary malignancy: report of three cases.

Feely MM, Gonzalo DH, Corbera M, Hughes SJ, Trevino JG.

J Gastrointest Surg. 2014 Sep;18(9):1710-5. doi: 10.1007/s11605-014-2568-3. Epub 2014 Jun 19.

PMID:
24944152
24.

A systematic approach to the preoperative medical evaluation of adults.

Collins CS, Feely MA, Daniels PR, Kebede EB, Mauck KF.

Hosp Pract (1995). 2014 Feb;42(1):52-64. doi: 10.3810/hp.2014.02.1092.

PMID:
24566597
25.

Two cases of lichen striatus with prolonged active phase.

Feely MA, Silverberg NB.

Pediatr Dermatol. 2014 Mar-Apr;31(2):e67-8. doi: 10.1111/pde.12261. Epub 2014 Jan 24.

PMID:
24456157
26.

In reply.

Feely MA, Mauck KF.

Am Fam Physician. 2013 Oct 1;88(7):424. No abstract available.

27.

Preparedness planning before mechanical circulatory support: a "how-to" guide for palliative medicine clinicians.

Swetz KM, Kamal AH, Matlock DD, Dose AM, Borkenhagen LS, Kimeu AK, Dunlay SM, Feely MA.

J Pain Symptom Manage. 2014 May;47(5):926-935.e6. doi: 10.1016/j.jpainsymman.2013.06.006. Epub 2013 Oct 2.

PMID:
24094703
28.

Characteristics and outcomes of adenosquamous carcinoma of the pancreas.

Simone CG, Zuluaga Toro T, Chan E, Feely MM, Trevino JG, George TJ Jr.

Gastrointest Cancer Res. 2013 May;6(3):75-9.

29.

Preoperative testing before noncardiac surgery: guidelines and recommendations.

Feely MA, Collins CS, Daniels PR, Kebede EB, Jatoi A, Mauck KF.

Am Fam Physician. 2013 Mar 15;87(6):414-8. Review.

30.

Safety of clopidogrel in hip fracture surgery.

Feely MA, Mabry TM, Lohse CM, Sems SA, Mauck KF.

Mayo Clin Proc. 2013 Feb;88(2):149-56. doi: 10.1016/j.mayocp.2012.11.007.

31.

Management of end-of-life care and of difficult behaviors associated with borderline personality disorder.

Feely MA, Havyer RD, Lapid MI, Swetz KM.

J Pain Symptom Manage. 2013 May;45(5):934-8. doi: 10.1016/j.jpainsymman.2012.04.004. Epub 2012 Aug 24. No abstract available.

PMID:
22921178
32.

Are there alternatives to hemodialysis for the elderly patient with end-stage renal failure?

Thorsteinsdottir B, Swetz KM, Feely MA, Mueller PS, Williams AW.

Mayo Clin Proc. 2012 Jun;87(6):514-6. doi: 10.1016/j.mayocp.2012.02.016. No abstract available.

33.

Balancing evidence-based medicine, justice in health care, and the technological imperative: a unique role for the palliative medicine clinician.

Swetz KM, Thorsteindottir B, Feely MA, Parsi K.

J Palliat Med. 2012 Apr;15(4):390-1. doi: 10.1089/jpm.2011.0443. No abstract available.

PMID:
22500478
34.

Cutaneous lymphatics and chronic lymphedema of the head and neck.

Feely MA, Olsen KD, Gamble GL, Davis MD, Pittelkow MR.

Clin Anat. 2012 Jan;25(1):72-85. doi: 10.1002/ca.22009. Review.

PMID:
22180138
35.

Assessment of reading behavior with an infrared eye tracker after 360° macular translocation for age-related macular degeneration.

Uppal G, Feely MP, Crossland MD, Membrey L, Lee J, da Cruz L, Rubin GS.

Invest Ophthalmol Vis Sci. 2011 Aug 17;52(9):6486-96. doi: 10.1167/iovs.10-5879.

PMID:
21596822
36.

Inappropriate application of nodule management guidelines in radiologist reports before and after revision of exclusion criteria.

Feely MA, Hartman TE.

AJR Am J Roentgenol. 2011 May;196(5):1115-9. doi: 10.2214/AJR.10.5141.

PMID:
21512078
37.

A novel program to promote competency and hospice and palliative medicine board certification.

Feely MA, Havyer RD, Carey EC, Swetz KM.

J Palliat Med. 2011 Mar;14(3):272-3. doi: 10.1089/jpm.2010.0455. No abstract available.

PMID:
21361834
38.

New and emerging therapies for the treatment of rheumatoid arthritis.

Feely MG.

Open Access Rheumatol. 2010 Jul 24;2:35-43. eCollection 2010. Review.

39.

Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.

Feely MG, O'Dell JR.

Curr Opin Rheumatol. 2010 May;22(3):316-20. doi: 10.1097/BOR.0b013e3283383f87. Review.

PMID:
20190639
40.

Depression: a psychiatric nursing theory of connectivity.

Feely M, Long A.

J Psychiatr Ment Health Nurs. 2009 Oct;16(8):725-37. doi: 10.1111/j.1365-2850.2009.01452.x.

PMID:
19744062
41.

Seaweed attachment to bedrock: biophysical evidence for a new geophycology paradigm.

Morrison L, Feely M, Stengel DB, Blamey N, Dockery P, Sherlock A, Timmins E.

Geobiology. 2009 Sep;7(4):477-87. doi: 10.1111/j.1472-4669.2009.00206.x. Epub 2009 Jul 15.

PMID:
19624752
42.

Therapeutic options for rheumatoid arthritis.

Feely MG, Erickson A, O'Dell JR.

Expert Opin Pharmacother. 2009 Sep;10(13):2095-106. doi: 10.1517/14656560903071043. Review.

PMID:
19606939
43.

The effect of age and fixation instability on retinotopic mapping of primary visual cortex.

Crossland MD, Morland AB, Feely MP, von dem Hagen E, Rubin GS.

Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3734-9. doi: 10.1167/iovs.07-1621. Epub 2008 Apr 25.

PMID:
18441304
44.

Early life experiences and their impact on our understanding of depression.

Feely M, Sines D, Long A.

J Psychiatr Ment Health Nurs. 2007 Jun;14(4):393-402.

PMID:
17517030
45.

Naming of depression: nursing, social and personal descriptors.

Feely M, Sines D, Long A.

J Psychiatr Ment Health Nurs. 2007 Feb;14(1):21-32. Review.

PMID:
17244002
46.

Psychological factors and use of antiepileptic drugs: pilot work using an objective measure of adherence.

Kemp S, Feely M, Hay A, Wild H, Cooper C.

Psychol Health Med. 2007 Jan;12(1):107-13.

PMID:
17129938
47.

The effect of font and line width on reading speed in people with mild to moderate vision loss.

Rubin GS, Feely M, Perera S, Ekstrom K, Williamson E.

Ophthalmic Physiol Opt. 2006 Nov;26(6):545-54.

PMID:
17040418
48.

Mosaic ring 20 with no detectable deletion by FISH analysis: Characteristic seizure disorder and literature review.

Zou YS, Van Dyke DL, Thorland EC, Chhabra HS, Michels VV, Keefe JG, Lega MA, Feely MA, Uphoff TS, Jalal SM.

Am J Med Genet A. 2006 Aug 1;140(15):1696-706.

PMID:
16835934
49.

New standardised texts for assessing reading performance in four European languages.

Hahn GA, Penka D, Gehrlich C, Messias A, Weismann M, Hyvärinen L, Leinonen M, Feely M, Rubin G, Dauxerre C, Vital-Durand F, Featherston S, Dietz K, Trauzettel-Klosinski S.

Br J Ophthalmol. 2006 Apr;90(4):480-4.

50.

Immune responses to AAV in a phase I study for Canavan disease.

McPhee SW, Janson CG, Li C, Samulski RJ, Camp AS, Francis J, Shera D, Lioutermann L, Feely M, Freese A, Leone P.

J Gene Med. 2006 May;8(5):577-88.

PMID:
16532510

Supplemental Content

Support Center